PodcastsEducationHematologic Oncology Update

Hematologic Oncology Update

Dr. Neil Love
Hematologic Oncology Update
Latest episode

135 episodes

  • Hematologic Oncology Update

    CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson

    23/03/2026 | 24 mins.
    Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.
    CME information and select publications here.
  • Hematologic Oncology Update

    Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review

    21/03/2026 | 29 mins.
    Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.
    CME information and select publications here.
  • Hematologic Oncology Update

    CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah

    13/03/2026 | 1h 3 mins.
    Dr Bijal Shah from Moffitt Cancer Center in Tampa, Florida, discusses the role of BiTEs in the management of ALL.
    CME information and select publications here.
  • Hematologic Oncology Update

    Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting

    11/03/2026 | 47 mins.
    Prof Constantine Tam from Monash University in Melbourne, Australia, reviews recent datasets and discusses their implications for current and future management of chronic lymphocytic leukemia.
    CME information and select publications here.
  • Hematologic Oncology Update

    Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review

    09/03/2026 | 19 mins.
    Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.
    CME information and select publications here.

More Education podcasts

About Hematologic Oncology Update

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
Podcast website

Listen to Hematologic Oncology Update, 6 Minute English and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features

Hematologic Oncology Update: Podcasts in Family